Prostatic Hyperplasia, Benign
16
0
1
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
13%
2 trials in Phase 3/4
30%
3 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (16)
Comparison of Concurrent Endoscopic Prostate Surgery With Botox-A Injection and Postoperative Medical Therapy in BPH Patients With Overactive Bladder Symptoms
Impact of Long-term Dutasteride Use on Perioperative Outcomes of HoLEP
Efficacy/ Safety of Product DNN.65.21.005 in Patients With Benign Prostatic Hyperplasia
HoLEP: Learning Curve Analysis and Comparison With TURP
Prostatic Arterial Embolization With SQUID (Ethylene Vinyl Alcohol Copolymer )
A 3 Months Duration Interventional Study Comparing Hemodynamic Parameters Between Bolus and Fractionated Group.
Observational Study to Compare Two Prostate Laser Enucleation Techniques in Terms of Urinary Incontinence
Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia
Transperineal Laser Ablation for Treatment of Benign Prostatic Obstruction
Open Randomized Clinical Trial to Evaluate the Effects of Intermittent Caloric Restriction in Patients With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Rezum I Pilot Study for Benign Prostatic Hyperplasia
Rezum FIM Optimization Study
Tadalafil Plus Tamsulosin for Male LUTS and ED
Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
ThuLEP vs. HoLEP vs. Monopolar Enucleation in Management of BPH